Pallas Capital Advisors LLC Makes New Investment in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
Pallas Capital Advisors LLC purchased a new position in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 19,797 shares of the biotechnology company’s stock, valued at approximately $148,000. A number of […]
Pallas Capital Advisors LLC purchased a new position in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 19,797 shares of the biotechnology company’s stock, valued at approximately $148,000. A number of […]
-logo-1200x675.png?v=20230608083651&w=240&h=240&zc=2){kind=logo}
